Analyst Ratings for Centessa Pharmaceuticals (CNTA) [Buys]
CNTA Rating Summary
CNTA Price Target Summary
- Highest: $15.00 (BMO Capital)
- Lowest: $5.00 (Goldman Sachs)
- Average: $9.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.80 (+8.2%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 77%
Avg. $ Target:
$9.80 (+8.2%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/15/2023 | Jefferies | Kelly Shi | Upgrade | Buy (Hold) |
11.00 (4.00) |
6.24 (9.06) |
45.19% | Details |
| 6/21/2023 | Evercore ISI | Umer Raffat | New Coverage | Outperform (N/A) |
N/A (N/A) |
5.50 (9.06) |
64.73% | Details |
 |
||||||||
|
||||||||
|
||||||||
